60-day peripheral nerve stimulation to reduce pain and improve function after acute thoracolumbar compression fracture
Official title: Effect of 60-day Peripheral Nerve Stimulation (PNS) in Alleviating Pain and Improving Function After Acute Thoracolumbar Compression Fracture
Run by Saint Peters University Hospital · NCT07079865 · Data updated 2026-11-12
This program will try 60-day SPRINT peripheral nerve stimulation in adult women with recent thoracolumbar compression fractures to see if it lowers pain and improves function.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 15 (estimated) |
| Sponsor | Saint Peters University Hospital Academic / other |
| Locations | 4 sites (Avenel, New Jersey and 3 other locations) |
| Status | Recruiting |
| Started | August 7, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT07079865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (18+) with primary osteoporosis and an acute or subacute thoracic or lumbar compression fracture within the past three months who report at least moderate pain (NRS ≥4) despite OTC therapies are the ideal candidates.
✕Probably not a fit
Patients with pathological fractures from malignancy or other non-osteoporotic causes, active infection, untreated coagulopathy, uncontrolled psychosocial illness, or other excluded conditions are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows adult women with osteoporosis who have thoracic or lumbar compression fractures less than three months old and receive a 60-day SPRINT peripheral nerve stimulation (PNS) implant. Pain (Numeric Rating Scale and Brief Pain Inventory) and patient-reported outcomes (PROMIS via the CareSense digital system) are collected one week before implantation and at 2 weeks, 3 months, and 6 months after implantation. Participants may be taking opioids at baseline but, per routine practice, no additional opioids will be prescribed during the PNS intervention. The primary focus is on short-term pain reduction with secondary analysis of function and quality of life over six months.
Why it matters
Potential benefit: If successful, 60-day PNS could reduce pain and improve daily function and quality of life for women with recent thoracolumbar compression fractures.
How similar studies have gone: Percutaneous short-term PNS systems such as SPRINT have shown pain reductions in other acute and postoperative pain settings, but their use specifically for thoracolumbar compression fractures is relatively new.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult females ages 18+ * Osteoporosis diagnosis with acute/subacute insufficiency fractures of the thoracic or lumbar spine identified on MRI or X-ray with significant pain and activity limitation. * Onset of pain from associated fracture should be less than 3 months. * Minimum pain should be 4 or greater (Moderate) on the NRS scale and/or impairing their daily activity. * Patients reported pain should be despite OTC medication trials of NSAIDs, Tylenol, lidocaine patches or similar medications. * Patients may be taking opioids while receiving treatment however as per routine practice, no additional opioids will be prescribed during the PNS intervention. Exclusion Criteria: * Patients with pathological fractures, other etiologies of fracture such as pagets disease, multiple myeloma, local or systemic infection, untreated coagulopathy, untreated psychosocial disease. * Other etiologies of osteoporosis other than primary osteoporosis will be excluded such as hyperparathyroidism, anorexia, malabsorption, hyperthyroidism, or overtreatment of hypothyroidism, chronic renal failure, cushing. * Patients with diminished mental capacity (mental condition that will inhibit their ability to complete the assessments) as determined by the investigator. * Patients with an active cardiac implant device such as a pacemaker or defibrillator.
Where it's running
-
University Orthopaedic Associates - Division of OrthoNJ
Avenel, New Jersey, United States Recruiting -
University Orthopaedic Associates - Division of OrthoNJ
Morganville, New Jersey, United States Recruiting -
University Center for Ambulatory Surgery (UCAS)
Somerset, New Jersey, United States Recruiting -
University Orthopaedic Associates - Division of OrthoNJ
Somerset, New Jersey, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Vessel-X Bone Filling Container System for Vertebral Augmentation
A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.
-
Nine-grid Zoning Method to guide vertebroplasty for osteoporotic vertebral fractures
This trial tests whether the Nine-grid Zoning Method can make percutaneous vertebroplasty safer and faster for adults with single-segment lumbar osteoporotic vertebral compression fractures.
-
Vertebroplasty versus sham to see if activity and mobility improve after osteoporotic vertebral fractures
This study tests whether vertebroplasty, compared with a sham procedure, increases physical activity and mobility in people aged 50+ with recent painful osteoporotic vertebral compression fractures.
-
Evaluating treatment outcomes for vertebral compression fractures
This study is testing how well a procedure called vertebroplasty helps adults with osteoporosis-related spine fractures feel better and improve their quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.